A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The primary objective of this study was to assess the safety, tolerability, and immunogenicity potential of romosozumab following multiple subcutaneous (SC) administrations in healthy men and postmenopausal women with low bone mass.
Epistemonikos ID: f351f2682d595ec7c80299aab099b51370320080
First added on: May 11, 2024